Bio-Techne (TECH) said Thursday it has entered into a strategic co-marketing and co-promotion agreement with Waters Corporation (WAT) to expand the reach of biotherapeutic characterization and development processes.
The companies plan to merge Bio-Techne's MauriceFlex System for charge separation with Waters' BioAccord LC-MS System for liquid chromatography mass spectrometry to provide solutions to optimize workflows, improve precision, and accelerate development timelines, the firm said.
Price: 70.62, Change: -0.79, Percent Change: -1.11
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。